Insider · CIK 0001758507

NOUGUES MAXIMO F

Reports to the SEC for 1 company · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001758507

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-06	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−9,386 sh	$8.26	−$77.6K	230,637
2026-02-18	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+46.7K sh	—	—	240,023
2026-02-18	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+66.5K sh	—	—	66,541
2026-01-07	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−6,405 sh	$5.88	−$37.7K	193,284
2026-01-06	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−4,540 sh	$5.84	−$26.5K	199,689
2025-07-09	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−3,935 sh	$3.54	−$13.9K	204,229
2025-07-08	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−5,587 sh	$3.53	−$19.7K	208,164
2025-02-07	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+61.5K sh	—	—	213,751
2025-02-07	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+85.1K sh	—	—	85,067
2025-01-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−10.2K sh	$3.15	−$32.2K	152,295
2024-07-17	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−4,156 sh	$3.70	−$15.4K	162,522
2024-07-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−5,295 sh	$3.27	−$17.3K	166,678
2024-02-12	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+43.3K sh	—	—	171,973
2024-02-12	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+59.9K sh	—	—	59,946
2024-01-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−15.7K sh	$4.49	−$70.3K	128,666
2023-07-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−14.7K sh	$3.31	−$48.6K	144,348
2023-02-10	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+58.6K sh	—	—	159,028
2023-02-10	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+81.4K sh	—	—	81,399
2023-01-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−10.5K sh	$4.18	−$43.9K	100,427
2022-12-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−159 sh	$4.50	−$715.15	110,926
2022-11-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−163 sh	$2.25	−$366.75	111,085
2022-10-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−165 sh	$2.34	−$385.341	111,248
2022-09-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−164 sh	$2.59	−$424.694	111,413
2022-08-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−161 sh	$2.89	−$465.29	111,577
2022-07-05	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−9,328 sh	$2.63	−$24.5K	111,738
2022-07-05	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−5,835 sh	$2.63	−$15.4K	64,625
2022-06-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−162 sh	$1.92	−$311.332	121,066
2022-05-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−165 sh	$2.34	−$386.117	121,228
2022-04-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−206 sh	$3.08	−$634.068	121,393
2022-03-03	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+62.2K sh	—	—	121,599
2022-03-03	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+88.8K sh	—	—	88,824
2022-03-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−169 sh	$2.26	−$382.278	59,423
2022-02-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−199 sh	$2.48	−$493.958	59,592
2022-01-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−7,484 sh	$3.19	−$23.9K	59,791
2021-12-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−162 sh	$2.95	−$477.9	67,275
2021-11-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−156 sh	$5.67	−$884.676	67,437
2021-10-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−161 sh	$6.20	−$998.216	67,593
2021-09-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−155 sh	$7.51	−$1,164.205	67,754
2021-08-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−154 sh	$7.54	−$1,161.483	67,909
2021-07-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−155 sh	$9.26	−$1,435.114	68,063
2021-06-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−152 sh	$10.74	−$1,632.632	68,218
2021-05-03	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−152 sh	$9.91	−$1,506.381	68,370
2021-04-05	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−155 sh	$9.80	−$1,519.45	68,522
2021-03-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−154 sh	$10.14	−$1,560.882	68,677
2021-02-17	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+55.6K sh	—	—	68,831
2021-02-17	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+78.2K sh	—	—	78,209
2021-02-02	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−179 sh	$12.26	−$2,194.665	13,236
2021-01-04	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Chief Financial Officer	SSale	−2,145 sh	$10.22	−$21.9K	13,415
2020-02-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Chief Financial Officer	AAward	+15.6K sh	—	—	15,560
2020-02-11	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+15.6K sh	—	—	15,567

Recent filings

Accepted (ET)
Jul 84
NOUGUES MAXIMO F0001437749-26-023077
SEC(opens sec.gov)
Feb 204
NOUGUES MAXIMO F0001437749-26-004946
SEC(opens sec.gov)
Jan 84
NOUGUES MAXIMO F0001437749-26-000921
SEC(opens sec.gov)
Jul 104
NOUGUES MAXIMO F0001437749-25-022551
SEC(opens sec.gov)
Feb 114
NOUGUES MAXIMO F0001437749-25-003461
SEC(opens sec.gov)
Jan 34
NOUGUES MAXIMO F0001437749-25-000365
SEC(opens sec.gov)
Jul 184
NOUGUES MAXIMO F0001437749-24-023022
SEC(opens sec.gov)
Jul 24
NOUGUES MAXIMO F0001437749-24-022067
SEC(opens sec.gov)
Feb 144
NOUGUES MAXIMO F0001437749-24-004216
SEC(opens sec.gov)
Jan 54
NOUGUES MAXIMO F0001437749-24-000768
SEC(opens sec.gov)
Jul 64
NOUGUES MAXIMO F0001437749-23-019525
SEC(opens sec.gov)
Feb 144
NOUGUES MAXIMO F0001437749-23-003382
SEC(opens sec.gov)
Jan 54
NOUGUES MAXIMO F0001437749-23-000547
SEC(opens sec.gov)
Dec 64
NOUGUES MAXIMO F0001437749-22-028558
SEC(opens sec.gov)

Companies

PUMA BIOTECHNOLOGY, INC.Chief Financial OfficerPBYI

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BLVD., SUITE 1700

LOS ANGELES, CA, 90024